This transformative agreement heralds the start of a collaborative venture poised to enhance the livestock and agricultural industries in Botswana and the broader region. The Chief Executive Officer (CEO) of Botswana Vaccine Institute (BVI), Andrew Madeswi, during his address at the ceremony, expressed immense pride and gratitude for the collaboration. He highlighted that this MoU signifies not only a partnership but also a shared vision to strengthen Botswana’s livestock and agricultural sectors.
"This MoU marks the beginning of an exciting and mutually beneficial partnership aimed at contributing towards bolstering the livestock and agricultural sector of our great nation and the region," he stated. "In an era of rapid advancements in animal health, it's imperative for organisations like ours to collaborate, optimising our capabilities and resources to robustly support agricultural growth. Our partnership aims to broaden our outreach and ensure that crucial veterinary products are readily available to local farmers via BAMB's extensive retail network," declared Madeswi. Reflecting on the MoU negotiations that began in 2023, Madeswi noted that numerous value-adding dimensions were explored to form the key elements of the agreement. "BVI, as a self-funding business, embraces collaborations through MoUs that support our strategic focus and attainment of tangible results," he emphasized. He also underscored the alignment between BVI and BAMB, both public bodies dedicated to providing animal health solutions and impacting the lives of Batswana engaged in agriculture.
